Evidence and tardive dyskinesia [9]

Lancet

Volumn 347, Issue 9016, 1996, Pages 1696-1697

  Soares, K ^a   McGrath, J ^a   Adams, C ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; ANTIHISTAMINIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

DRUG OVERDOSE; HUMAN; LETTER; METHODOLOGY; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

EID: 0030004448     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91525-1     Document Type: Letter

References (4)

1. Na Buckley Aj Smith Evidence-based medicine in toxicology: where is the evidence? Lancet 347 1996 1067 1069
2. American Psychiatric Association Tardive dyskinesia: a task force report of the American Psychiatric Association Washington DC 1992
3. Jl Cadet Jb Lohr Possible involvement of free radicals in neuroleptic-induced movement disorders Ann N Y Acad Sci 570 1989 176 185
4. Kvs Soares Jj McGrath Schizophrenia and neuroleptic-induced tardive dyskinesia: efficacy of vitamin E C. Adams J. Anderson J. De Jesus Mari Schizophrenia module of the Cochrane Database of Systematic Reviews 1996 BMJ Publishing Group London (available in the Cochrane Library)